Clinical Financial Services (CFS) Partners withALM's Strategic Research Institute to Share Best Practices inManaging the Grant Payment Process.

NEW YORK -- ALM's Strategic Research Institute today announced that Clinical Financial Services (CFS) will be sharing their best practices in grant payment procedures with conference attendees at the upcoming Global Biopharmaceutical Outsourcing conference on February 25-26, 2008 in Philadelphia, PA. The conference website is www.almevents.com/globaloutsource.

According to Managing Director, Kathy Stewart of ALM's Strategic Research Institute, "this unique session will highlight the key issues and challenges relating to the delivery of investigator payments and how to use those payments to get more value out of EDC solutions and improve investigator relationships." Through this session conference attendees will gain a deeper understanding of the potential impacts of poor investigator payment practices and will benefit from reviewing a detailed anatomy of a quality grant payment solution presented by Clinical Financial Services' Director of Pharmaceutical Operations, Jim DiCesare. Ms. Stewart elaborates "Jim brings more than fifteen years of accounting, finance, contracting and clinical trial experience to the table, and is responsible for the delivery of all CFS services to sponsors and clinical research organizations (CROs). Conference attendees will benefit from not only the best practices generated by this organization, but from Jim's depth of experience and subject-matter expertise."

This two-day Global Biopharmaceutical Outsourcing conference focuses not only on the best practices for sound grant payment procedures to enhance the site-sponsor relationship, but also on current and future structures for pre-clinical outsourcing. Speakers from Abbott, Centocor, Daiichi Sankyo, Horizon Therapeutics, MedImmune, Medtronic Vascular, Pfizer, Purdue Pharma L.P., Sanofi Aventis, Satori and Wyeth will discuss: biotech experiences in preclinical outsourcing, recent growth of outsourcing preclinical drug safety studies, budget forecasts and management for outsourced projects, gauging costs and time advantages of clinical outsourcing, managing financial, legal and quality control obstacles, governance structures and relationship management, risks and rewards structures and collaborative deal structures to meet all parties' targets.

For complete program agenda and information including registration and hotel booking, please visit www.almevents.com/globaloutsource or call 800.599.4950/212.967.0095.